(Q40533572)

21 September 2017

title

Selegiline increases heme oxygenase-1 expression and the cytotoxicity produced by dopamine treatment of neuroblastoma SK-N-SH cells (English)

1 reference

21 September 2017

1 reference

C R M Rieder

1

1 reference

21 September 2017

A C Williams

series ordinal

2

1 reference

21 September 2017

D B Ramsden

series ordinal

3

1 reference

21 September 2017

language of work or name

English

0 references

publication date

22 June 2004

1 reference

Brazilian Journal of Medical and Biological Research

21 September 2017

published in

1 reference

21 September 2017

volume

37

1 reference

21 September 2017

issue

7

1 reference

21 September 2017

page(s)

1055-1062

1 reference

Biochemistry of Parkinson's disease with special reference to the dopaminergic systems.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

An introduction to the free radical hypothesis in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Oxidative damage in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Human heme oxygenase-2: characterization and expression of a full-length cDNA and evidence suggesting that the two HO-2 transcripts may differ by choice of polyadenylation signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Rapid induction of heme oxygenase 1 mRNA and protein by hyperthermia in rat brain: heme oxygenase 2 is not a heat shock protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Evidence for oxidative stress in Pick disease and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Neural heme oxygenase-1 expression in idiopathic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Regulation of heme oxygenase-1 expression by dopamine in cultured C6 glioma and primary astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Dopamine induces the expression of heme oxygenase-1 by human endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

(-)deprenyl increases activities of superoxide dismutase and catalase in certain brain regions in old male mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

(-)Deprenyl increases the life span as well as activities of superoxide dismutase and catalase but not of glutathione peroxidase in selective brain regions in Fischer rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Complex I, iron, and ferritin in Parkinson's disease substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Cellular management of iron in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Does carbon monoxide have a physiological function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Carbon monoxide: a putative neural messenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2004000700015

10.1590/S0100-879X2004000700015

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference